Oncological Formulations: An Overview of the Latest Advancements in Cancer Treatment
When cancer therapy officially started, the history of cancer treatment was quite different. Researchers have been successful in introducing innovative cancer drugs that are more effective and efficient than conventional drugs used to cure the disease. Making new oncology drug formulations has been more crucial in recent research trends, generating numerous significant developments. This article discusses a few of those recent breakthroughs in oncology drug formulations.
1. Nanoformulations:
Nanotechnology has opened up a world of opportunities for cancer treatment. Among the most important advances in oncological formulations are nanoformulations. These are very small (under 100 nanometers) particles that are used to deliver medicines directly into cancer cells. Nanoformulations are more effective and have fewer side effects compared to traditional chemotherapy. They increase the bioavailability of the drugs and improve drug permeation in the targeted cancer cells, making them an exciting prospect for cancer treatment.
2. Liposomal Formulations:
Another fascinating field of study in oncological formulations includes liposomal formulations. They are spherical structures formed of phospholipid bilayers that enclose medications. They have numerous benefits over the current chemotherapeutic drugs, such as improved delivery, increased efficiency, reduced toxicity, and increased patient compliance. They are suitable for targeting specific cells within the body and thus make excellent cancer treatment agents.
3. Antibody-Drug Conjugates:
The Antibody-Drug Conjugate (ADC) is a compound that consists of an antigen-specific antibody and a cytotoxic agent. It is interesting how ADCs are successfully targeting only the tumour cells without damaging the healthy ones. In such a way, it is possible to have a high therapeutic index, and therefore, the amount of drug required to kill the tumour is smaller compared to conventional chemotherapy.
4. Microsphere Formulations:
Microspheres are spherical entities that are formed using biodegradable synthetic or natural polymers. These microspheres are used as a drug delivery system. These microspheres offer a constant release of the drug with minimal side effects, and they allow the drug to be directly delivered into the tumour without harming the healthy cells. Microsphere preparations have shown their efficacy against several cancers such as breast, lung, and prostate cancers.
5. Protease-Sensitive Formulations:
Protease-sensitive formulations act in such a way that they will be broken down once the drug reaches the cancer cell. They are composed of certain peptides that will only be cleaved by certain proteases that exist in large quantities in the tumour rather than in healthy tissue. Protease-sensitive formulations allow the drug to reach the target cell safely with minimal damage to the healthy cells.
In oncology, there has been so much progress in formulating new treatments, and new formulations are always coming up to help improve the health of cancer patients. Targeted therapies, among other things, have contributed immensely to the development of many new formulations that have improved the treatment of cancer tremendously. We may expect even greater improvements in oncological formulations as fresh research becomes readily available.